Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

Don P. Wolf, Tomonari Hayama, Shoukhrat Mitalipov

    Research output: Contribution to journalComment/debate

    4 Citations (Scopus)

    Abstract

    The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

    Original languageEnglish (US)
    Pages (from-to)2659
    Number of pages1
    JournalEMBO Journal
    Volume36
    Issue number17
    DOIs
    StatePublished - Sep 1 2017

    Fingerprint

    Conflict of Interest
    Mitochondrial Genome
    Mitochondrial Genes
    Mitochondrial DNA
    Genes
    Health
    Inventors
    Oocytes
    corrigendum
    Therapeutics

    ASJC Scopus subject areas

    • Neuroscience(all)
    • Molecular Biology
    • Immunology and Microbiology(all)
    • Biochemistry, Genetics and Molecular Biology(all)

    Cite this

    Corrigendum to : Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606). / Wolf, Don P.; Hayama, Tomonari; Mitalipov, Shoukhrat.

    In: EMBO Journal, Vol. 36, No. 17, 01.09.2017, p. 2659.

    Research output: Contribution to journalComment/debate

    @article{ba88a91cef814ddc8c4d41a0688e5dfb,
    title = "Corrigendum to: Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)",
    abstract = "The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.",
    author = "Wolf, {Don P.} and Tomonari Hayama and Shoukhrat Mitalipov",
    year = "2017",
    month = "9",
    day = "1",
    doi = "10.15252/embj.201797843",
    language = "English (US)",
    volume = "36",
    pages = "2659",
    journal = "EMBO Journal",
    issn = "0261-4189",
    publisher = "Nature Publishing Group",
    number = "17",

    }

    TY - JOUR

    T1 - Corrigendum to

    T2 - Mitochondrial genome inheritance and replacement in the human germline (The EMBO Journal, (2017), 36, 15, (2177-2181), 10.15252/embj.201797606)

    AU - Wolf, Don P.

    AU - Hayama, Tomonari

    AU - Mitalipov, Shoukhrat

    PY - 2017/9/1

    Y1 - 2017/9/1

    N2 - The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

    AB - The conflict of interest section contains information that is incorrect. The correct conflict of interest statement is as follows: Oregon Health & Science University has the patent entitled “Method for mitochondrial DNA replacement in oocytes”. SM is an inventor of the patent. SM is also a founder and CEO of Mitogenome Therapeutics, Inc. DPW and TH declare that they have no conflict of interest.

    UR - http://www.scopus.com/inward/record.url?scp=85028521849&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85028521849&partnerID=8YFLogxK

    U2 - 10.15252/embj.201797843

    DO - 10.15252/embj.201797843

    M3 - Comment/debate

    AN - SCOPUS:85028521849

    VL - 36

    SP - 2659

    JO - EMBO Journal

    JF - EMBO Journal

    SN - 0261-4189

    IS - 17

    ER -